Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,682.60
+5.10 (0.30%)
Mar 10, 2026, 12:09 PM IST
Gland Pharma Revenue
Gland Pharma had revenue of 16.95B INR in the quarter ending December 31, 2025, with 22.49% growth. This brings the company's revenue in the last twelve months to 61.13B, up 6.70% year-over-year. In the fiscal year ending March 31, 2025, Gland Pharma had annual revenue of 56.17B, down -0.85%.
Revenue (ttm)
61.13B
Revenue Growth
+6.70%
P/S Ratio
4.52
Revenue / Employee
14.05M
Employees
4,351
Market Cap
276.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 56.17B | -482.18M | -0.85% |
| Mar 31, 2024 | 56.65B | 20.40B | 56.29% |
| Mar 31, 2023 | 36.25B | -7.76B | -17.64% |
| Mar 31, 2022 | 44.01B | 9.38B | 27.08% |
| Mar 31, 2021 | 34.63B | 8.30B | 31.51% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Glenmark Pharmaceuticals | 165.10B |
| Alkem Laboratories | 142.53B |
| Ipca Laboratories | 95.06B |
| Piramal Pharma | 88.71B |
| Emcure Pharmaceuticals | 88.50B |
| Alembic Pharmaceuticals | 72.67B |
| Laurus Labs | 67.22B |
| Ajanta Pharma | 52.02B |
Gland Pharma News
- 6 days ago - Gland Pharma gets USFDA tentative approval for Brimonidine Tartrate Ophthalmic Solution - Business Upturn
- 14 days ago - Pharma sector stocks down today, Feb 24: AstraZeneca Pharma falls 1.72%, Alembic Pharma down 1.38%, Gland Pharma drops 1.24% - Business Upturn
- 4 weeks ago - Gland Pharma gets USFDA nod for Zoledronic Acid Injection for US market - Business Upturn
- 5 weeks ago - Gland Pharma shares rally sharply over 8% as Q3 revenue rises 22.5% YoY to Rs Rs 1,695 crore, net profit up 27.7% - Business Upturn
- 5 weeks ago - Top stocks for trade today, Jan 29: Wipro, Mahindra, Garden Reach, Gland Pharma, Larsen & Toubro and more - Business Upturn
- 5 weeks ago - Gland Pharma Ltd (NSE:GLAND) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and ... - GuruFocus
- 5 weeks ago - Q3 2026 Gland Pharma Ltd Earnings Call Transcript - GuruFocus
- 5 weeks ago - Gland Pharma Q3 Results: Revenue jumps 22.5% YoY to Rs 1,695 crore, net profit up 27.5% YoY - Business Upturn